Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Mahavilda M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Mankind Pharma Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Mahavilda M 500mg/50mg Tablet

Diabetol-DM 500mg/50mg tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications, such as renal impairment and vision loss, and may lessen the risk of cardiovascular events like heart attacks and strokes. Diabetol-DM 500mg/50mg may be used independently or in conjunction with other antidiabetic therapies. Optimal efficacy requires adherence to a balanced diet and consistent exercise. Dosage is personalized based on individual health status, blood glucose readings, and concurrent medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Effective blood sugar control prevents future complications. Maintaining the prescribed diet and exercise regimen is crucial for managing diabetes; lifestyle choices significantly impact disease control. Common adverse effects include diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, fatigue, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential side effect when used with insulin or sulfonylureas; proper recognition and management are essential. This medication is not universally suitable. Prior to use, disclose any history of renal, hepatic, or cardiac disease, pancreatic issues, or significant alcohol consumption to your physician. Pregnant or lactating individuals should seek medical counsel before initiating treatment. Drug interactions are possible; inform your doctor of all medications to ensure safety. Alcohol should be minimized due to its potential to lower blood glucose levels. Your physician will monitor renal function and blood glucose levels before, during, and after treatment.

Uses of Mahavilda M 500mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Mahavilda M 500mg/50mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Mahavilda M 500mg/50mg Tablet whole; do not damage it by chewing, crushing, or breaking. Administer this medicine with a meal.

Common Side effects of Mahavilda M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Mahavilda M 500mg/50mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Mahavilda M 500mg/50mg tablets with food.

How Mahavilda M 500mg/50mg Tablet works:

Each Mahavilda M 500mg/50mg tablet contains a dual antidiabetic medication formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Mahavilda M 500mg/50mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Mahavilda M 500mg/50mg Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks before prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Mahavilda M 500mg/50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Mahavilda M 500mg/50mg tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised.

LiverLiverUNSAFE

The use of Mahavilda M 500mg/50mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Mahavilda M 500mg/50mg Tablet :

Should you forget to take a Mahavilda M 500mg/50mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Mahavilda M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Mahavilda M 500mg/50mg Tablet

Mahavilda M 500mg/50mg Tablets rarely cause hypoglycemia by themselves, but this can happen if calorie intake is inadequate. Hypoglycemia symptoms—nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness—are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always keep glucose tablets, honey, or fruit juice readily available.
Nausea and vomiting are possible side effects of Mahavilda M 500mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Consult your doctor before taking any other medication.
Patients with allergies to Mahavilda M 500mg/50mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication safely and ensure it remains inaccessible to children, pets, and others.
Mahavilda M 500mg/50mg Tablet combines the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts pancreatic insulin release. This combination is contraindicated for individuals under 18.
Mahavilda M 500mg/50mg Tablet can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Mahavilda M 500mg/50mg Tablet and seek immediate medical attention.
Prolonged use of Mahavilda M 500mg/50mg Tablet can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia and neurological complications.
Using Mahavilda M 500mg/50mg Tablet as directed by your doctor is safe. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, upset stomach, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (especially if you also take insulin or sulphonylurea) may occur. Report any persistent issues to your doctor.
Mahavilda M 500mg/50mg Ta...
172
MRP 210
18% off